Answers are grounded in this paper and cite their sources.
SSRIs are considered a safe first-line treatment for adolescents with generalized anxiety disorder, with escitalopram and sertraline showing favorable safety profiles. Close monitoring for suicidality and adverse effects is crucial, particularly in the early treatment stages.
No takes yet. Share an insight, caveat, or question.
Tripdatabase (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: